A letter to the FTC drafted by Dan Gustafson and other AAI advisors concludes that the Express Scripts acquisition of Medco Health Solutions will likely cause anticompetitive harm in the provision of PBM services to the large plan sponsors market segment. Because of the large PBMs’ vertical integration and enhanced buyer power, the merger will also likely cause anticompetitive harm in the specialty pharmacy and mail order pharmacy market segments.
